By Robert Hand Health economics data play an increasingly important role in getting pharmaceuticals accepted for the drug formularies established by health insurance plans and regulatory authorities. A drug manufacturer…
Details
By HOC Editor, Mary Gabb ([email protected]) When speaking to non-economists, do you end up feeling that you’ve made a difficult science completely unintelligible? It doesn’t have to be that way.…
Details
A pharmaceutical executive working in the field of health outcomes tells former HOC editor David Woods how he deals with this issue. The best way to communicate value in a…
Details
By Amy Rothman Schonfeld This spring will mark the inaugural biennial conference of the newly formed American Society of Health Economists (ASHE). The conference, titled Economics of Population Health, is…
Details
By Robert Hand In the United States, there has been growing acceptance of the Academy of Managed Care Pharmacy (AMCP) Drug Dossier format for submitting consistent, evidence-based information about drugs.…
Details
By Ruth Whittington Remember last month’s exhortation to break the firewalls between health economics and sales and marketing? Here is an opposing view from a prominent member of the industry,…
Details
By David Woods Nothing is calculated to agitate health economists more than the perception that what you do is somehow inexact, or “soft”. Yet no matter how precise and rigorous…
Details
By David Woods, former editor At a recent meeting on healthcare communications, one speaker referred to what he called new innovations. Perhaps his enthusiasm made up for a lack of…
Details
By Ruth Whittington ([email protected]) One of the issues most frequently mentioned when we surveyed you was the seemingly unbridgeable gap between how health economists think, and how marketing and sales…
Details
George Orwell, whose prose was spare and pure, offered six rules for effective writing: * Never use a metaphor, simile, or other figure of speech which you are used to…
Details